Efficacy
tumor
TUMOR
The tumor response was evaluated in all patients enrolled in this study. The ORR was 6.7% (95% CI: 0.8%–22.1%), whereas the DCR was 73.3% (95% CI: 54.1–87.7%). The tumor responses are summarized in Table Response to treatment.Abbreviation: CI, confidence interval.Kaplan–Meier curve of progression‐free survival. Ticks indicate the patients for whom data were censored on June 30, 2015. CI, confidence interval; CPT‐11, irinotecan.Kaplan–Meier curve of overall survival. Ticks indicate the patients for whom data were censored on June 30, 2015. CI, confidence interval; CPT‐11, irinotecan.Kaplan–Meier curve of progression‐free survival classified by age (a), PS (b), and previous regimen number (c). Ticks indicate the patients for whom data were censored on June 30, 2015. CI, confidence interval; PS, performance status.Kaplan–Meier curve of overall survival classified by age (a), PS (b), and previous regimen number (c). Ticks indicate the patients for whom data were censored on June 30, 2015. CI, confidence interval; PS, performance status.